Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.18 +0.01 (+0.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Receivables (2011 - 2019)

Updated

Chemomab Therapeutics (CMMB) recorded Receivables of $408,000 in Q4 2019, down 88.1% from $3.42 million a year earlier and down 67.0% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Receivables (2011 - 2019) Analysis & Trends

Starting with Q4 2017, Chemomab Therapeutics' Receivables history includes 5 quarters.

  • Across earlier years, Receivables came in at $3.42 million in FY2018 (+725.1%) and $415,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 19.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 13.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 12.49 Bn
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 408,000.00
Sep 30, 2019 1.24 Mn
Jun 30, 2019 885,000.00
Dec 31, 2018 3.42 Mn
Dec 31, 2017 415,000.00
Dec 31, 2012 426,834.16
Sep 30, 2012 555,285.08
Jun 30, 2012 981,109.07
Dec 31, 2011 216,511.65
Sep 30, 2011 -111,677.85
Jun 30, 2011 125,951.96
API Access

Chemomab Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CMMB&period=max&api_key=YOUR_API_KEY